PLX:NYSEAMERICAN
Protalix Biotherapeutics Inc
$2.29
arrow_upward
+3.15%(+0.070) 1D
$2.29
arrow_upward
+0.07% (+0.0015)bedtimeAfter hours
Closed: Aug 17, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLX...
Open
$2.24
High
$2.36
Low
$2.22
Mkt. cap
184.51M
Avg. vol.
687.90K
Volume
2.00
P/E ratio
12.55
52-wk high
$3.19
52-wk low
$1.46
EPS
$0.18
Beta
0.02
Shares outstanding
80.57M
No. of employees
226
Open
$2.24
High
$2.36
Low
$2.22
Mkt. cap
184.51M
Avg. vol.
687.90K
Volume
2.00
P/E ratio
12.55
52-wk high
$3.19
52-wk low
$1.46
EPS
$0.18
Beta
0.02
Shares outstanding
80.57M
No. of employees
226
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 month ago
PLX Q1 2026 Earnings: Significant Earnings Beat Driven by Key Milestone Events - Healthcare Earnings Report
Profile
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
About Protalix Biotherapeutics Inc
CEODror Bashan
Employees226
Founded1993
HeadquartersKarmiel, North District, Israel
SectorBiotechnology
Websiteprotalix.com
AI content may include mistakes. Learn more